Timothy B. Lowinger
2023
In 2023, Timothy B. Lowinger earned a total compensation of $1.7M as Senior Vice President, Chief Science and Technology Officer at Mersana Therapeutics, a 43% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $110,465 |
|---|---|
| Option Awards | $817,290 |
| Salary | $470,063 |
| Stock Awards | $284,250 |
| Other | $7,000 |
| Total | $1,689,068 |
Lowinger received $817.3K in option awards, accounting for 48% of the total pay in 2023.
Lowinger also received $110.5K in non-equity incentive plan, $470.1K in salary, $284.3K in stock awards and $7K in other compensation.
Rankings
In 2023, Timothy B. Lowinger's compensation ranked 671st out of 2,978 executives tracked by ExecPay. In other words, Lowinger earned more than 77.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 671 out of 2,978 | 78th |
Division Manufacturing | 377 out of 1,637 | 77th |
Major group Chemicals And Allied Products | 256 out of 906 | 72nd |
Industry group Drugs | 252 out of 869 | 71st |
Industry Pharmaceutical Preparations | 161 out of 627 | 74th |
Source: SEC filing on April 26, 2024.
Lowinger's colleagues
We found six more compensation records of executives who worked with Timothy B. Lowinger at Mersana Therapeutics in 2023.
2023
Anna Protopapas
Mersana Therapeutics
Chief Executive Officer
2023
Martin Huber
Mersana Therapeutics
Chief Executive Officer
2023
Arvin Yang
Mersana Therapeutics
Chief Medical Officer
2023
Brian DeSchuytner
Mersana Therapeutics
Chief Financial Officer
2023
Alejandra Carvajal
Mersana Therapeutics
Chief Legal Officer
2023
Mohan Bala
Mersana Therapeutics
Senior Vice President, Chief Development Officer
News
Mersana Therapeutics CEO Anna Protopapas' 2023 pay jumps 56% to $4.5M
April 26, 2024
Mersana Therapeutics CEO Anna Protopapas' 2022 pay falls 66% to $2.8M
April 28, 2023
Mersana Therapeutics CEO Anna Protopapas' 2021 pay jumps 226% to $8.3M
April 29, 2022
Mersana Therapeutics Chief Medical Officer Arvin Yang receives $4.5M in 2020
April 27, 2021
Mersana Therapeutics CEO Anna Protopapas' 2019 pay falls 33% to $1.7M
April 20, 2020
Mersana Therapeutics CEO Anna Protopapas' 2018 pay jumps 184% to $2.6M
April 23, 2019